Smoking Behavior and Smoking Cessation among Head and Neck Cancer Patients

Head and Neck Cancer: Emerging Perspectives

Volumn , Issue , 2003, Pages 105-200

  Schnoll, Robert A ^a   Lerman, Caryn ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902403902     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012239990-9/50014-X     Document Type: Chapter

References (159)

1. Clayman G.L., Lippman S.M., Laramore G.E., Hong W.K. Neoplasms of the head and neck. Cancer Medicine 2000, 1174-1226. Decker, Baltimore. 5th Ed. J.F. Holland (Ed.).
2. USDHHS Reducing Tobacco Use: A Report of the Surgeon General-Executive Summary 2000, USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Hamilton, Ontario, Canada.
3. Maier H., Weidauer H. Alcohol drinking and tobacco smoking are the chief risk factors for ENT tumors: Increased incidence of mouth cavity, pharyngeal, and laryngeal carcinomas. Fortshr. Med. 1995, 113:157-160.
4. Zheng W., McLaughlin J.K., Chow W.H., Chien H.T., Blot W.J. Risk factors for cancers of the nasal cavity and paranasal sinuses among white men in the United States. Am. J. Epidemiol. 1993, 138:965-972.
5. Cinciripini P.M., Gritz E.R., Tsoh J.Y., Skaar K.L. Smoking cessation and cancer prevention. Psycho-Oncology 1998, Oxford Univ. Press, Atlanta, CA. J.C. Holland (Ed.).
6. Gritz E.R. Smoking and smoking cessation in cancer patients. Br. J. Addict. 1991, 86:549-554.
7. Moadel A.B., Ostroff J.S., Schantz S.P. Head and neck Cancer. Psycho-Oncology 1998, Oxford Univ. Press, New York. J.C. Holland (Ed.).
8. Lippman S.M., Hong W.K. Retinoid chemoprevention of upper aerodigestive tract carcinogensis. Important Advances in Oncology 1992, 93-109. Lippincott, New York. V.T. Devita, S. Hellman, S.A. Rosenberg (Eds.).
9. Fiore M.C., Bailey W.C., Cohen S.J., et al. Treating Tobacco Use and Dependence 2000, USDHHS Public Health Service, Philadelphia.
10. Hecht J.P., Emmons K.M., Brown R.A., Everett K.D., Farrell N.C., Hitchcock P., Sales S.D. Smoking interventions for patients with cancer: Guidelines for nursing practice. Oncol. Nurs. For. 1994, 21:1657-1666.
11. Browman G.P., Wong G., Hodson I., Sathya J., Russell R., McAlpine L., Skingley P., Levine M.N. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N. Engl. J. Med. 1993, 328:59-63.
12. De Boer M.F., Van den Borne B., Pruyn J.F.A., Ryckman R.M., Volovics L., Knegt P.P., Meeuwis C.A., Mesters I., Verwoerd C.D. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: Results of a 6-year longitudinal study. Cancer 1998, 83:2567-2579.
13. Stevens M.H., Gardner J.W., Parkin J.L., Johnson L.P. Head and neck cancer survival and lifestyle change. Arch. Otolaryngol. 1983, 109:746-749.
14. de Graeff A., de Leeuw J.R., Ros W.J., Hordijk G.J., Blijham G.H., Winnubst J.A. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur. J. Cancer 2001, 37:332-339.
15. Moore C. Cigarette smoking and cancer of the mouth, pharynx and larynx. JAMA 1971, 218:553-558.
16. Silverman S., Gorsky M., Greenspan D. Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/orophayngeal cancers. J. Am. Dent. Assoc. 1983, 106:33-35.
17. Day G.L., Blot W.J., Shore R.E., McLaughlin J.K., Austin D.F., Greenberg R.S., Liff J.M., Preston-Martin S., Sarker S., Schoenberg J.B., Fraumerni J.F. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. JNCI 1994, 86:131-137.
18. Hiyama T., Sato T., Yoshino K., Tsukuma H., Hanai A., Fujimoto I. Second primary cancer following laryngeal cancer with special reference to smoking habits. Japan J. Cancer Res. 1992, 83:334-339.
19. Fountzilas G., Kosmidis P., Beer M., Sridhar K.S., Banis K., Vristios A., Daniilidis J. Ann. Oncol. 1992, 3:553-558.
20. Des Rochers C., Dische S., Saunders M.I. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin. Oncol. 1992, 4:214-216.
21. Benowitz N.L. Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med. 1998, 319:1318-1330.
22. Korsten M.A., Rosman A.S., Fishbein S., Shlein R.D., Goldberg H.E., Biener A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am. J. Med. 1991, 90:701-706.
23. McCarthy G.M., Awde J.D., Ghandi H., Vincent M., Kocha W.I. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol. 1998, 34:484-490.
24. Rugg T., Saunders M.L., Dische S. Smoking and mucosal reactions to radiotherapy. Br. J. Radiat. 1990, 63:554-556.
25. Dresler C.M., Roper C., Patterson G.A., Cooper J.D. Effect of physician advice on smoking cessation in patients undergoing thoractomy. ABS Chest 1993, 104:18.
26. USDHHS The health consequences of smoking. Nicotine Addiction: A Report of the Surgeon General 1988, USDHHS, Public Health Service, Center for Disease Control, Centers for Health Promotion and Education, Office on Smoking and Health, Rockville, MD.
27. Whittet H.B., Lund J.V., Brockbank M., Feyerbend C. Serum cotinine as an objective marker for smoking habit in head and neck malignancy. J. Laryngol. Otol. 1991, 105:1039.
28. Karim A.B., Snow G.B., Siek H.T., Njo K.H. The quality of voice in patients irradiated for laryngeal carcinoma. Cancer 1983, 51:47-49.
29. Taylor S.E. Health Psychology 1995, Mcgraw-Hill, Rockville, MD. 3rd Ed.
30. USDHHS The Health Benefits of Smoking Cessation: A Report of the Surgeon General 1990, U.S. Government Printing Office, New York.
31. Deleyiannis F.W., Thomas D.B., Vaughan T.L., Davis S. Alcoholism: Independent predictor of survival in patients with head and neck cancer. J. Natl. Cancer Inst. 1996, 88:542-549.
32. Spitz M.R., Fueger J.J., Chamberlain R.M., et al. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J. Cancer Educ. 1990, 5:109-113.
33. Orleans C.T., Rotberg H., Quade D., Lees P. A hospital quit-smoking consult service: Pilot evaluation and intervention model. Prev. Med. 1990, 19:198-212.
34. Ostroff J.S., Spiro R.H., Kraus D.H. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 1995, 75:569-576.
35. Gritz E.R., Schacherer C., Koehly L., Nielsen I.R., Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 1999, 21:420-427.
36. Christensen A.J., Moran P.J., Ehlers S.L., Raichle K., Karnell L., Funk G. Smoking and drinking behavior in patients with head and neck cancer: Effects of behavioral self-blame and perceived control. J. Behav. Med. 1999, 22:407-418.
37. Bronheim H., Strain J.J., Biller H.F. Psychiatric aspects of head and neck surgery, 1. New surgical techniques and psychiatric consequences. Gen Hosp. Psychiatry 1991, 13:165-176.
38. Huber F.T., Bartels H., Siewert J.R. Treatment of postoperative alcohol withdrawal syndrome after esophageal resection. Langenbecks Arch. Chir. Suppl. II Verh. Dtsch. Ges. Chir. 1990, 1141-1143.
39. Hasuo S., Koyama Y., Kinoshita N., Tanaka H., Ajiki W., Yoshino K., Furukawa H., Oshima A. Smoking behavior and cognition for smoking cessation after diagnosis of head and neck cancer or stomach cancer. Nippon Koshu Eisei Zasshi 1998, 45:732-739.
40. Silverman S., Griffith M. Smoking characteristics of patients with oral carcinoma and the risk for second oral primary carcinoma. J. Am. Dent. Assoc. 1972, 85:637-640.
41. Vander Ark W., DiNardo L.J., Oliver D.S. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope 1997, 107:888-892.
42. Schnoll R.A., Malstrom M., James C., Rothman R.L., Miller S.M., Ridge J.A., Movsas B., Langer C., Unger M., Goldberg M. Longitudinal predictors of continued smoking among cancer patients. Proc. Am. Soc. of Prev. Oncol. 2001.
43. Prochaska J.O., Velicer W.F. The transtheoretical model of health behavior change. Am. J. Health Prom. 1997, 12:38-48.
44. Sobell L.C., Brown J., Leo G.I., Sobell M.B. The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend. 1996, 42:49-54.
45. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. J. Consult. Clin. Psychol. 2000, 68:134-144.
46. Gariti P.W., Alterman A.I., Ehrman R.N., Pettinati H.M. Reliability and validity of the aggregate method of determining number of cigarettes smoked per day. Am. J. Addict. 1998, 7:283-287.
47. Engstrom P.E., Clapper M., Schnoll R.A., Orleans C.T. Prevention of tobacco-related cancers. Cancer Medicine 2000, 127-140. Decker, Washington D.C. 5th Ed. J.F. Holland (Ed.).
48. Gritz E.R., Carr C.R., Rapkin D., Abermayor E., Chang L.C., Wong W., Belin T.R., Calcaterra T., Robbins T., Chonkich G., Beumer J., Ward P.H. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidem. Biomark. 1993, 2:261-270.
49. Payne T.J., Smith P.O., McCracken L.M., McSherry W.C., Antony M.M. Assessing nicotine dependence: A comparison of the Fagerstrom Tolerance Questionnaire (FTQ) with the Fagerstrom Test for Nicotine Dependence (FTND) in a clinical sample. Add Behav. 1994, 19:307-317.
50. Etter J.F., Vu Duc T., Perneger T.V. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addicson. 1999, 94:269-281.
51. Schnoll R.A., Miller S., Malstrom M., James C.L., Unger M., Langer C., Ridge J.A., Goldberg M., Movsas B. Predictors and rates of smoking among cancer patients. Proc. Am. Soc. Prev. Oncol., Bethesda, MD 2000.
52. Miller N.S., Gold M.S. Comorbid cigarette and alcohol addiction: Epidemiology and treatment. J. Addict. Dis. 1998, 17:55-66.
53. Sher J.J., Gotham H.J., Erickson D.J., Wood P.K. A prospective, high risk study of the relationship between tobacco dependence and alcohol use disorders. Alcohol Clin. Exp. Res. 1996, 20:485-492.
54. McNair P.M., Lorr M., Droppleman L. Profile of Mood States Manual 1992, Educational and Industrial Testing Services, Hamilton, Ontario, Canada.
55. Osler M., Prescott E. Psychosocial, behavioral, and health determinants of successful smoking cessation: A longitudinal study of Danish adults. Tob. Cont. 1998, 7:262-267.
56. Sciamanna C.N., Hoch J.S., Duke G.C., Fogle M.N., Ford D.E. Comparison of five measures of motivation to quit smoking among a sample of hospitalized smokers. J. Gen. Intern. Med. 2000, 15:16-23.
57. Fava J.L., Ruggiero L., Grimley D.M. The development and structural confirmation of the Rhode Island Stress and Coping Inventory. J. Behav. Med. 1998, 21:601-611.
58. Berarducci A., Lengacher C.A. Self-efficacy: An essential component of advanced-practice nursing. Nurs. Conn. 1998, 11:55-67.
59. Shiffman S., Balabanis M.H., Paty J.A., Engberg J., Gwaltney C.J., Liu K.S., Gnys M., Hickcox M., Paton S.M. Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol. 2000, 19:315-323.
60. Pohl J.M., Martinelli A., Antonakos C. Predictors of participation in a smoking cessation intervention group among low-income women. Addict Behav. 1998, 23:699-704.
61. Gulliver S.B., Hughes J.R., Solomon L.J., Dey A.N. An investigation of self-efficacy, partner support and daily stresses as predictors of relapse to smoking in self-quitters. Addiction 1995, 90:767-772.
62. Matheny K.B., Weatherman K.E. Predictors of smoking cessation and maintenance. J. Clin. Psychol. 1998, 54:223-225.
63. Rosal M.C., Ockene J.K., Hurley T.G., Alan K., Hebert J.R. Effectiveness of nicotine-containing gum in the physiciandelivered smoking intervention study. Prev. Med. 1998, 27:262-267.
64. Scholte R.H., Breteler M.H. Withdrawal symptoms and previous attempts to quit smoking: Associations with self-efficacy. Subst. Use Misuse 1997, 32:133-148.
65. Stuart K., Borland R., McMurray N. Self-efficacy, health locus of control, and smoking cessation. Addict Behav. 1994, 19:1-12.
66. Woodby L.L., Windsor R.A., Snyder S.W., Kohler C.L., Diclemente C.C. Predictors of smoking cessation during pregnancy. Addiction 1999, 94:283-292.
67. Halpern M.T., Schmier J.K., Ward K.D., Klesges R.C. Smoking cessation in hospitalized patients. Respir. Care 2000, 45:330-336.
68. Meland E., Maeland J.G., Laerum E. The importance of self-efficacy in cardiovascular risk factor change. Scand. J. Public Health 1999, 27:11-17.
69. Bursey M., Craig D. Attitudes, subjective norm, perceived behavioral control, and intentions related to adult smoking cessation after coronary artery bypass graft surgery. Public Health Nurs. 2000, 17:460-467.
70. Hanson M.J. The theory of planned behavior applied to cigarette smoking in African-American, Puerto Rican, and non-Hispanic white teenage females. Nurs. Res. 1997, 46:155-162.
71. Hill A.J., Boudreau F., Amyot E., Dery D., Godin G. Predicting the stages of smoking acquisition according to the theory of planned behavior. J. Adolesc. Health 1997, 21:107-115.
72. Nguyen M.N., Beland F., Otis J. Is the intention to quit smoking influenced by other heart-healthy lifestyle habits in 30- to 60-year-old men?. Addict. Behav. 1998, 23:23-30.
73. Norman P., Conner M., Bell R. The theory of planned behavior and smoking cessation. Health Psychol. 1999, 18:89-94.
74. Weinstein N.D. Accuracy of smokers' risk perceptions. Ann. Behav. Med. 1998, 20:135-140.
75. USDHHS Reducing the Health Consequences of Smoking 1989, U.S. Department of Health and Human Services, Public Health Service, San Diego, CA.
76. Ayanian J.Z., Cleary P.D. Perceived risks of heart disease and cancer among cigarette smokers. JAMA 1999, 281:1019-1021.
77. McCoy S.B., Gibbons F.X., Reix T.J., Gerrard M., Luus C.A., Sufka A.V. Perceptions of smoking risk as a function of smoking status. J. Behav. Med. 1992, 15:469-488.
78. Strecher V.J., Kreuter M., Korbin S.C. Do cigarette smokers have unrealistic perceptions of their heart attack, cancer, and stroke risks?. J. Behav. Med. 1995, 18:45-54.
79. Weinstein N.D. Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. J. Behav. Med. 1987, 10:481-500.
80. Kviz F.J., Crittenden K.S., Belzer L.J., Warnecke R.B. Psychosocial factors and enrollment in a televised smoking cessation program. Health Educ. Quart. 1991, 18:445-461.
81. Halpern M.T., Warner K.E. Differences in former smokers' beliefs and health status following smoking cessation. Am. J. Prev. Med. 1994, 10:31-37.
82. Prochaska J.O. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol. 1994, 13:47-51.
83. Ahijevych K., Parsley L.A. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav. 1999, 24:115-120.
84. Dijkstra A., de Vries H., Bakker M. Pros and cons of quitting, self-efficacy, and the stages of change in smoking cessation. J. Consult. Clin. Psychol. 1996, 64:758-763.
85. Etter J.F., Perneger T.V. Associations between the stages of change and the pros and cons of smoking in a longitudinal study of Swiss smokers. Addict. Behav. 1999, 24:419-424.
86. Fava J.L., Velicer W.F., Prochaska J.O. Applying the transtheoretical model to a representative sample of smokers. Addict. Behav. 1995, 20:189-203.
87. Herzog T.A., Abrams D.B., Emmons K.M., Linnan L.A., Shadel W.G. Do processes of change predict smoking stage movements? A prospective analysis of the transtheoretical model. Health Psychol. 1999, 18:369-375.
88. King T.K., Marcus B.H., Pinto B.M., Emmons K.M., Abrams D.B. Cognitive-behavioral mediators of changing multiple behaviors: Smoking and a sedentary lifestyle. Prev. Med. 1996, 25:684-691.
89. Quattrocki E., Baird A., Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv. Rev. Psychiatry 2000, 8:99-110.
90. Hall S.M., Munoz R.F., Reus V.I., Sees K.L. Nicotine, negative affect, and depression. J. Consult. Clin. Psychol. 1993, 61:761-767.
91. Kinnunen T., Doherty K., Militello F.S., Garvey A.J. Depression and smoking cessation: Characteristics of depressed smokers and effects of nicotine replacement. J. Consult. Clin. Psychol. 1996, 64:791-798.
92. Anda R.F., Williamson D.F., Escobedo L.G., Mast E.E., Giovino G.A. Depression and the dynamics of smoking: A national perspective. JAMA 1990, 264:1541-1545.
93. Covey J.C. Depressive mood, the single-parent home, and adolescent smoking. Am. J. Pub. Health 1990, 80:1330-1333.
94. Glassman A.H. Cigarette smoking: Implications for psychiatric illness. Am. J. Psychiatry 1993, 150:546-553.
95. Rausch J.L., Nichinson B., Lamke C., Matloff J. Influence of negative affect on smoking cessation treatment outcome: A pilot study. Br. J. Addict. 1990, 85:929-933.
96. Kugaya A., Akechi T., Okamura H., Mikami I., Uchitomi Y. Correlates of depressed mood in ambulatory head and neck cancer patients. Psycho-Oncol. 1999, 8:494-499.
97. Breitbart W. Identifying patients at risk for, and treatment of major complications of cancer. Supp. Care. Cancer 1995, 3:45-60.
98. Morton R.P., Davies A.D.M., Baker J., Baker G., Stell P.M. Quality of life in treated head and neck cancer patients: A preliminary report. Clin. Otolaryngol. 1984, 9:181-185.
99. Kugaya A., Akechi T., Okulama T., Nakano T., Mikami I., Okamura H., Uchitomi Y. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000, 88:2817-2823.
100. de Graeff A., de Leeuw R.J., Ros W.J.G., Hordijk G.J., Batterman J.J., Blijham G.H., Winnubst J.A.M. A prspective study on the quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck 1999, 21:291-2196.
101. de Graeff A., de Leeuw R.J., Ros W.J.G., Hordijk G.-J., Blijham G.H., Winnubst J.A.M. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 2000, 22:398-407.
102. de Leeuw R.J., de Graeff A., Ros W.J.G., Hordijk G.J., Blijham G.H., Winnubst J.A.M. Negative and positive influences of social support on depression in patients with head and neck cancer: A prospective study. Psycho-Oncol. 2000, 9:20-28.
103. de Leeuw R.J., de Graeff A., Ros W.J.G., Blijham G.H., Hordijk G.J., Winnubst J.A.M. Prediction of depressive symptomatology after treatment of head and neck cancer: The influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 2000, 22:799-807.
104. Carmody T.P. Affect regulation, nicotine addiction, and smoking cessation. J. Psychoact. Drugs 1989, 21:331-342.
105. Hughes J.R. Clonidine, depression, and smoking cessation. JAMA 1988, 259:2901-2902.
106. Lerman C., Audrain J., Orleans C.T., Boyd R., Gold K., Main D., Caporaso N. Investigation of mechanisms linking depressed mood to nicotine dependence. Addict. Behav. 1996, 21:9-19.
107. Cinciripini P.M., Hecht S.S., Henningfield J.E., Manley M.W., Kramer B. Tobacco addiction: Implication for treatment and cancer prevention. JNCI 1997, 89:1852-1867.
108. Henningfield J.E., Schuh L.M., Jarvik M.E. Pathophysiology of tobacco dependence. Psychopharmacology: The Fourth Generation of Progress 1995, 1715-1730. Raven Press, Rockville, MD. F.E. Bloom, D.J. Kupfer (Eds.).
109. Pomerleau O.F., Kardia S.L. Introduction to the featured section: Genetic research on smoking. Health Psychol. 1999, 18:3-6.
110. Noble E.P. The DRD2 gene, smoking, and lung cancer. JNCI 1998, 90:343-347.
111. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., Weinberger D.R. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
112. Bergen A.W., Caporaso N. Cigarette smoking. JNCI 1999, 91:1365-1375.
113. 1 receptor gene in addictive behaviors. Mol. Psychiatry 1997, 2:44-56.
114. 2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics 1996, 6:73-79.
115. 4 receptors and the risk of cigarette smoking in African Americans and Caucasians. Cancer Epidemiol. Biomark. Prev. 1998, 7:453-458.
116. 2 dopamine receptor gene and cigarette smoking: A reward gene?. Med. Hypoth. 1994, 42:257-260.
117. 2 receptor gene and smoking status in lung cancer patients. JNCI 1998, 90:358-363.
118. Bierut L.J., Rice J.P., Edenberg H.J., Goate A., Foroud T., Cloninger C.R., Begleiter H., Conneally P.M., Crowe R.R., Hesselbrock V., Li T.K., Nurnberger J.I., Porjesz B., Schuckit M.A., Reich T. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am. J. Med. Genet. 2000, 14:299-302.
119. Singleton A.B., Thomson J.H., Morris C.M., Court J.A., Lloyd S., Cholerton S. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics 1998, 8:125-128.
120. Lerman C., Caporaso N.E., Audrain J., Main D., Bowman E.D., Lockshin B., Boyd N.R., Sheilds P. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999, 18:14-20.
121. Sabol S., Nelson M.L., Fisher C., Gunzerath L., Brody C.L., Hu S., Sirota L.A., Marcus S., Greenberg B.D., Lucas F.R., Benjamin J., Murphy D.L., Hamer D.H. A genetic association for cigarette smoking behavior. Health Psychol. 1999, 18:7-13.
122. Jorm A.F., Henderson A.S., Jacomb P., Christensen H., Korten A.E., Rodgers B., Tan X., Easteal S. Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey. Am. J. Med. Gen. 2000, 12:331-334.
123. Gilbert D.G. Personality, psychopathology, tobacco use, and individual differences in effects of nicotine. Smoking: Individual Differences, Psychopathology, and Emotion 1995, 149-176. Taylor and Francis, New York. K.P. Baker, H. Seltzer (Eds.).
124. Audrain J., Lerman C., Gomez-Caminero A., Boyd N.R., Orleans C.T. The role of trait anxiety in nicotine dependence. J. Appl. Biobehav. Res. 1998, 3:29-42.
125. Lerman C., Shields P.G., Audrain J., Main D., Cobb B., Boyd N.R., Caporaso N. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomark. Prev. 1998, 7:253-255.
126. Hu S., Brody C.L., Fisher C., Gunzerath L., Nelson M.L., Sabol S., Sirota L., Marcus S.E., Greenberg B.D., Murphy D.L., Hamer D.H. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol. Psychiatry 2000, 5:181-188.
127. Lerman C., Caporaso N.E., Audrain J., Main D., Boyd N.R., Sheilds P. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry 2000, 5:189-192.
128. Lerman C., Caporaso N.E., Bush A., Zheng Y-L., Audrain J., Main D., Shields P.G. Tryptophan hyroxylase gene variant and smoking behavior. Am. J. Med. Gen. 2002, 105:513-520.
129. Sullivan P.F., Jiang X., Neale M.C., Kendler K.S., Straub R.E. Association of the tryptophan hyroxylase gene with smoking initiation but not progression to nicotine dependence. Am. J. Med. Gen. 2002, 105:479-484.
130. Pianezza M.L., Sellers E.M., Tyndale R.F. Nicotine metabolism defect reduces smoking. Nature 1998, 393:750.
131. Oscarson M., Gullsten H., Rautio A., Bernal M.L., Sinues B., Dahl M.L., Stengard J.H., Pelkonen O., Raunio H., Ingelman-Sundberg M. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett. 1998, 438:201-205.
132. London S.J., Idle J.R., Daly A.K., Coetzee G.A. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 1999, 353:898-899.
133. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Gen. 1993, 52:506-516.
134. Cinciripini P.M., McClure J.B. Smoking cessation: Recent developments in behavioral and pharmacologic interventions. Oncology (Huntingt) 1998, 12:249-256.
135. Wetter D.W., Fiore M.C., Gritz E.R., Lando H.A., Stitzer M.L., Hasselblad V., Baker T.B. The Agency for Health Care Policy and Research findings and implications for psychologists. Am. Psychol. 1998, 53:657-669.
136. Fiore M.C., Novotny T.E., Pierce J.P., Giovino G.A., Hatziandreu E.J., Newcomb P.A., Surawicz T.S., Davis R.M. Methods used to quit smoking in the United States. Do cessation programs help?. JAMA 1990, 263:2760-2765.
137. Orleans C.T., Rotberg H., Quade D., Lees P. Hospital quite smoking consult service: Pilot evaluation and intervention model. Prev. Med. 1990, 19:198-212.
138. Abrams D.B., Orleans C.T., Niaura R.S., Goldstein M.G., Prochaska J.O., Velicer W. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: A combined stepped-care and matching model. Ann. Behav. Med. 1996, 18:290-304.
139. Curry S.J. Self-help interventions for smoking cessation. J. Consul. Clin. Psychol. 1993, 61:790-803.
140. Glynn T., Boyd G.M., Gruman J.C. Essential elements of self-help/minimal intervention strategies for smoking cessation. Health Educ. Quart. 1990, 17:329-345.
141. Lando H.A., Pirie P.L., McGovern P.G., Pechacek T.F., Swim J., Loken B. A comparison of self-help approaches to smoking cessation. Addict. Behav. 1991, 16:183-193.
142. Fiore M.C., Bailey W.C., Cohen S.J., et al. Treating Tobacco Use and Dependence 2000, USDHHS, Public Health Service, Washington, DC.
143. Kottke T.E. Observing the delivery of smoking-cessation interventions. Am. J. Prev. Med. 1998, 14:71-72.
144. Fiore M.C., Bailey W.C., Cohen S.J., et al. Smoking Cessation: Information for Specialists. Clinical Practice Guideline 1996, USDHHS, Public Health Service, Agency for Health Care Policy and Research and Centers for Disease Control and Prevention, Rockville, MD.
145. Glynn T. Physicians and a smoke-free society. Arch. Intern. Med. 1988, 148:1013-1016.
146. Kottke T., Battista R.N., DeFriese G.H., Brekke M.L. Attributes of successful smoking cessation interventions in medical practice: A meta-analysis of 39 controlled trials. JAMA 1988, 259:2883-2889.
147. Goldstein M.G., Niaura R., Willey-Lessne C., DePue J., Eaton C., Rakowski W., Dube C. Physicians counseling smokers. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions. Arch. Intern. Med. 1997, 23:1313-1319.
148. Anderson C.B., Wetter D.W. Behavioral and pharmacologic approaches to smoking cessation. Cancer Met. Rev. 1997, 16:393-404.
149. Ferry L.H., Robbins A.S., Scariati P.D., et al. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride. Circulation 1992, 86:I-671. [Abstract].
150. Ferry L.H., Burchette R.J. Efficacy of bupropion for smoking cessation in non-depressed smokers. J. Addict. Dis. 1994, 13:249.
151. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., Khayrallah M.A., Schroeder D.R., Glover P.N., Sullivan C.R., Croghan I.T., Sullivan P.M. A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. 1997, 23:1195-1202.
152. Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto M.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. 1999, 340:685-691.
153. Emmons K.M., Goldstein M.G. Smokers who are hospitalized: A window of opportunity for cessation interventions. Prev. Med. 1992, 21:262-269.
154. Orleans C.T., Kristeller J.L., Gritz E.R. Helping hospitalized smokers quit: New directions for treatment and research. J. Consult. Clin. Psychol. 1993, 61:778-789.
155. Stanislaw A.E., Wewers M.E. A smoking cessation intervention with hospitalized surgical cancer patients: A pilot study. Cancer Nurs. 1994, 17:81-86.
156. Griebel B., Wewers M.E., Baker C.A. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer. Oncol. Nurs. Forum 1998, 25:897-902.
157. Browning K.K., Ahijevych K.L., Ross P., Wewers M.E. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncol. Nurs. Forum 2000, 27:1248-1254.
158. Glassman A.H. Psychiatry and cigarettes. Arch. Gen. Psychiatry 1998, 55:692-693.
159. Schilling A., Conaway M.R., Wingate P.J., Atkins J.N., Berkowitz I.M., Clamon G.H., DiFino S.M., Vinciguerra V. Recruiting cancer patients to participate in motivating their relatives to quit smoking: A cancer control study of the Cancer and Leukemia Group B (CALGB 9072). Cancer 1997, 79:152-160.